Home » Topics » Regulatory » Patents

Patents
RSS

New thrombin inhibitors from Novartis

April 3, 1997

Vasopressin antagonists from JT

April 2, 1997

Hokuriku discloses agents for urinary incontinence

April 2, 1997

Selective CB2 receptor agonists prepared by Merck Frosst

April 2, 1997

Novel antitumor agents from Universidad Complutense

April 2, 1997

Centocor describes peptide inhibitors of selectin binding

April 2, 1997

MS&D prepares antimigraine pyrrolo-pyridine derivatives

April 2, 1997

Endothelin antagonists from SmithKline Beecham

April 2, 1997

Wyeth-Ayerst describes antiinflammatory agents

April 2, 1997

Lilly continues to develop compounds for postmenopausal syndrome

April 2, 1997

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...